Medical Care
Global Blood Brain Barrier Technologies Market Research Report 2024
- Apr 15, 24
- ID: 168836
- Pages: 86
- Figures: 162
- Views: 23
The blood-brain barrier controls the exchange of substances between the blood and the brain. It protects the brain from toxins and pathogens, but at the same time it can make the delivery of therapeutic agents to the brain more difficult.
The global Blood Brain Barrier Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Brain Barrier Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Brain Barrier Technologies.
Report Scope
The Blood Brain Barrier Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Brain Barrier Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Brain Barrier Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company.
Bristol-Myers Squibb Company
Pfizer, Inc.
Johnson and Johnson Services, Inc.
Fabre-Kramer Pharmaceuticals, Inc.
Bioasis Technologies Inc.
Abliva AB
JCR Pharmaceuticals Co., Ltd.
Segment by Type
Bispecific Antibody RMT Approach
Trojan Horse Approach
Increasing Permeability
Passive Diffusion
Others
Segment by Application
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Brain Barrier Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Blood Brain Barrier Technologies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Blood Brain Barrier Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Brain Barrier Technologies.
Report Scope
The Blood Brain Barrier Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blood Brain Barrier Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blood Brain Barrier Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company.
Bristol-Myers Squibb Company
Pfizer, Inc.
Johnson and Johnson Services, Inc.
Fabre-Kramer Pharmaceuticals, Inc.
Bioasis Technologies Inc.
Abliva AB
JCR Pharmaceuticals Co., Ltd.
Segment by Type
Bispecific Antibody RMT Approach
Trojan Horse Approach
Increasing Permeability
Passive Diffusion
Others
Segment by Application
Alzheimer’s Disease
Epilepsy
Parkinson’s Disease
Multiple Sclerosis
Hunter’s Syndrome
Brain Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Brain Barrier Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Brain Barrier Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bispecific Antibody RMT Approach
1.2.3 Trojan Horse Approach
1.2.4 Increasing Permeability
1.2.5 Passive Diffusion
1.2.6 Others
1.3 Market by Application
1.3.1 Global Blood Brain Barrier Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Alzheimer’s Disease
1.3.3 Epilepsy
1.3.4 Parkinson’s Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Brain Barrier Technologies Market Perspective (2019-2030)
2.2 Blood Brain Barrier Technologies Growth Trends by Region
2.2.1 Global Blood Brain Barrier Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Brain Barrier Technologies Historic Market Size by Region (2019-2024)
2.2.3 Blood Brain Barrier Technologies Forecasted Market Size by Region (2025-2030)
2.3 Blood Brain Barrier Technologies Market Dynamics
2.3.1 Blood Brain Barrier Technologies Industry Trends
2.3.2 Blood Brain Barrier Technologies Market Drivers
2.3.3 Blood Brain Barrier Technologies Market Challenges
2.3.4 Blood Brain Barrier Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Brain Barrier Technologies Players by Revenue
3.1.1 Global Top Blood Brain Barrier Technologies Players by Revenue (2019-2024)
3.1.2 Global Blood Brain Barrier Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Blood Brain Barrier Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Brain Barrier Technologies Revenue
3.4 Global Blood Brain Barrier Technologies Market Concentration Ratio
3.4.1 Global Blood Brain Barrier Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Brain Barrier Technologies Revenue in 2023
3.5 Blood Brain Barrier Technologies Key Players Head office and Area Served
3.6 Key Players Blood Brain Barrier Technologies Product Solution and Service
3.7 Date of Enter into Blood Brain Barrier Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Brain Barrier Technologies Breakdown Data by Type
4.1 Global Blood Brain Barrier Technologies Historic Market Size by Type (2019-2024)
4.2 Global Blood Brain Barrier Technologies Forecasted Market Size by Type (2025-2030)
5 Blood Brain Barrier Technologies Breakdown Data by Application
5.1 Global Blood Brain Barrier Technologies Historic Market Size by Application (2019-2024)
5.2 Global Blood Brain Barrier Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Brain Barrier Technologies Market Size (2019-2030)
6.2 North America Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Brain Barrier Technologies Market Size by Country (2019-2024)
6.4 North America Blood Brain Barrier Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Brain Barrier Technologies Market Size (2019-2030)
7.2 Europe Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Brain Barrier Technologies Market Size by Country (2019-2024)
7.4 Europe Blood Brain Barrier Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Brain Barrier Technologies Market Size (2019-2030)
8.2 Asia-Pacific Blood Brain Barrier Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Brain Barrier Technologies Market Size (2019-2030)
9.2 Latin America Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Brain Barrier Technologies Market Size by Country (2019-2024)
9.4 Latin America Blood Brain Barrier Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Brain Barrier Technologies Market Size (2019-2030)
10.2 Middle East & Africa Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.1.3 Teva Pharmaceutical Industries Ltd. Blood Brain Barrier Technologies Introduction
11.1.4 Teva Pharmaceutical Industries Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.1.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Detail
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Blood Brain Barrier Technologies Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Eli Lilly and Company.
11.3.1 Eli Lilly and Company. Company Detail
11.3.2 Eli Lilly and Company. Business Overview
11.3.3 Eli Lilly and Company. Blood Brain Barrier Technologies Introduction
11.3.4 Eli Lilly and Company. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.3.5 Eli Lilly and Company. Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Detail
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Blood Brain Barrier Technologies Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Detail
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Blood Brain Barrier Technologies Introduction
11.5.4 Pfizer, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.5.5 Pfizer, Inc. Recent Development
11.6 Johnson and Johnson Services, Inc.
11.6.1 Johnson and Johnson Services, Inc. Company Detail
11.6.2 Johnson and Johnson Services, Inc. Business Overview
11.6.3 Johnson and Johnson Services, Inc. Blood Brain Barrier Technologies Introduction
11.6.4 Johnson and Johnson Services, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.6.5 Johnson and Johnson Services, Inc. Recent Development
11.7 Fabre-Kramer Pharmaceuticals, Inc.
11.7.1 Fabre-Kramer Pharmaceuticals, Inc. Company Detail
11.7.2 Fabre-Kramer Pharmaceuticals, Inc. Business Overview
11.7.3 Fabre-Kramer Pharmaceuticals, Inc. Blood Brain Barrier Technologies Introduction
11.7.4 Fabre-Kramer Pharmaceuticals, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.7.5 Fabre-Kramer Pharmaceuticals, Inc. Recent Development
11.8 Bioasis Technologies Inc.
11.8.1 Bioasis Technologies Inc. Company Detail
11.8.2 Bioasis Technologies Inc. Business Overview
11.8.3 Bioasis Technologies Inc. Blood Brain Barrier Technologies Introduction
11.8.4 Bioasis Technologies Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.8.5 Bioasis Technologies Inc. Recent Development
11.9 Abliva AB
11.9.1 Abliva AB Company Detail
11.9.2 Abliva AB Business Overview
11.9.3 Abliva AB Blood Brain Barrier Technologies Introduction
11.9.4 Abliva AB Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.9.5 Abliva AB Recent Development
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Detail
11.10.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.10.3 JCR Pharmaceuticals Co., Ltd. Blood Brain Barrier Technologies Introduction
11.10.4 JCR Pharmaceuticals Co., Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.10.5 JCR Pharmaceuticals Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Blood Brain Barrier Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Bispecific Antibody RMT Approach
1.2.3 Trojan Horse Approach
1.2.4 Increasing Permeability
1.2.5 Passive Diffusion
1.2.6 Others
1.3 Market by Application
1.3.1 Global Blood Brain Barrier Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Alzheimer’s Disease
1.3.3 Epilepsy
1.3.4 Parkinson’s Disease
1.3.5 Multiple Sclerosis
1.3.6 Hunter’s Syndrome
1.3.7 Brain Cancer
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Blood Brain Barrier Technologies Market Perspective (2019-2030)
2.2 Blood Brain Barrier Technologies Growth Trends by Region
2.2.1 Global Blood Brain Barrier Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Blood Brain Barrier Technologies Historic Market Size by Region (2019-2024)
2.2.3 Blood Brain Barrier Technologies Forecasted Market Size by Region (2025-2030)
2.3 Blood Brain Barrier Technologies Market Dynamics
2.3.1 Blood Brain Barrier Technologies Industry Trends
2.3.2 Blood Brain Barrier Technologies Market Drivers
2.3.3 Blood Brain Barrier Technologies Market Challenges
2.3.4 Blood Brain Barrier Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Blood Brain Barrier Technologies Players by Revenue
3.1.1 Global Top Blood Brain Barrier Technologies Players by Revenue (2019-2024)
3.1.2 Global Blood Brain Barrier Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Blood Brain Barrier Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Blood Brain Barrier Technologies Revenue
3.4 Global Blood Brain Barrier Technologies Market Concentration Ratio
3.4.1 Global Blood Brain Barrier Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Blood Brain Barrier Technologies Revenue in 2023
3.5 Blood Brain Barrier Technologies Key Players Head office and Area Served
3.6 Key Players Blood Brain Barrier Technologies Product Solution and Service
3.7 Date of Enter into Blood Brain Barrier Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Blood Brain Barrier Technologies Breakdown Data by Type
4.1 Global Blood Brain Barrier Technologies Historic Market Size by Type (2019-2024)
4.2 Global Blood Brain Barrier Technologies Forecasted Market Size by Type (2025-2030)
5 Blood Brain Barrier Technologies Breakdown Data by Application
5.1 Global Blood Brain Barrier Technologies Historic Market Size by Application (2019-2024)
5.2 Global Blood Brain Barrier Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Blood Brain Barrier Technologies Market Size (2019-2030)
6.2 North America Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Blood Brain Barrier Technologies Market Size by Country (2019-2024)
6.4 North America Blood Brain Barrier Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Blood Brain Barrier Technologies Market Size (2019-2030)
7.2 Europe Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Blood Brain Barrier Technologies Market Size by Country (2019-2024)
7.4 Europe Blood Brain Barrier Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Blood Brain Barrier Technologies Market Size (2019-2030)
8.2 Asia-Pacific Blood Brain Barrier Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Blood Brain Barrier Technologies Market Size (2019-2030)
9.2 Latin America Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Blood Brain Barrier Technologies Market Size by Country (2019-2024)
9.4 Latin America Blood Brain Barrier Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Blood Brain Barrier Technologies Market Size (2019-2030)
10.2 Middle East & Africa Blood Brain Barrier Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceutical Industries Ltd.
11.1.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.1.3 Teva Pharmaceutical Industries Ltd. Blood Brain Barrier Technologies Introduction
11.1.4 Teva Pharmaceutical Industries Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.1.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Detail
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Blood Brain Barrier Technologies Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Development
11.3 Eli Lilly and Company.
11.3.1 Eli Lilly and Company. Company Detail
11.3.2 Eli Lilly and Company. Business Overview
11.3.3 Eli Lilly and Company. Blood Brain Barrier Technologies Introduction
11.3.4 Eli Lilly and Company. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.3.5 Eli Lilly and Company. Recent Development
11.4 Bristol-Myers Squibb Company
11.4.1 Bristol-Myers Squibb Company Company Detail
11.4.2 Bristol-Myers Squibb Company Business Overview
11.4.3 Bristol-Myers Squibb Company Blood Brain Barrier Technologies Introduction
11.4.4 Bristol-Myers Squibb Company Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.4.5 Bristol-Myers Squibb Company Recent Development
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Detail
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Blood Brain Barrier Technologies Introduction
11.5.4 Pfizer, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.5.5 Pfizer, Inc. Recent Development
11.6 Johnson and Johnson Services, Inc.
11.6.1 Johnson and Johnson Services, Inc. Company Detail
11.6.2 Johnson and Johnson Services, Inc. Business Overview
11.6.3 Johnson and Johnson Services, Inc. Blood Brain Barrier Technologies Introduction
11.6.4 Johnson and Johnson Services, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.6.5 Johnson and Johnson Services, Inc. Recent Development
11.7 Fabre-Kramer Pharmaceuticals, Inc.
11.7.1 Fabre-Kramer Pharmaceuticals, Inc. Company Detail
11.7.2 Fabre-Kramer Pharmaceuticals, Inc. Business Overview
11.7.3 Fabre-Kramer Pharmaceuticals, Inc. Blood Brain Barrier Technologies Introduction
11.7.4 Fabre-Kramer Pharmaceuticals, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.7.5 Fabre-Kramer Pharmaceuticals, Inc. Recent Development
11.8 Bioasis Technologies Inc.
11.8.1 Bioasis Technologies Inc. Company Detail
11.8.2 Bioasis Technologies Inc. Business Overview
11.8.3 Bioasis Technologies Inc. Blood Brain Barrier Technologies Introduction
11.8.4 Bioasis Technologies Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.8.5 Bioasis Technologies Inc. Recent Development
11.9 Abliva AB
11.9.1 Abliva AB Company Detail
11.9.2 Abliva AB Business Overview
11.9.3 Abliva AB Blood Brain Barrier Technologies Introduction
11.9.4 Abliva AB Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.9.5 Abliva AB Recent Development
11.10 JCR Pharmaceuticals Co., Ltd.
11.10.1 JCR Pharmaceuticals Co., Ltd. Company Detail
11.10.2 JCR Pharmaceuticals Co., Ltd. Business Overview
11.10.3 JCR Pharmaceuticals Co., Ltd. Blood Brain Barrier Technologies Introduction
11.10.4 JCR Pharmaceuticals Co., Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024)
11.10.5 JCR Pharmaceuticals Co., Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Blood Brain Barrier Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bispecific Antibody RMT Approach
Table 3. Key Players of Trojan Horse Approach
Table 4. Key Players of Increasing Permeability
Table 5. Key Players of Passive Diffusion
Table 6. Key Players of Others
Table 7. Global Blood Brain Barrier Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Blood Brain Barrier Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Blood Brain Barrier Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Blood Brain Barrier Technologies Market Share by Region (2019-2024)
Table 11. Global Blood Brain Barrier Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Blood Brain Barrier Technologies Market Share by Region (2025-2030)
Table 13. Blood Brain Barrier Technologies Market Trends
Table 14. Blood Brain Barrier Technologies Market Drivers
Table 15. Blood Brain Barrier Technologies Market Challenges
Table 16. Blood Brain Barrier Technologies Market Restraints
Table 17. Global Blood Brain Barrier Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Blood Brain Barrier Technologies Market Share by Players (2019-2024)
Table 19. Global Top Blood Brain Barrier Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Brain Barrier Technologies as of 2023)
Table 20. Ranking of Global Top Blood Brain Barrier Technologies Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Blood Brain Barrier Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Blood Brain Barrier Technologies Product Solution and Service
Table 24. Date of Enter into Blood Brain Barrier Technologies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Brain Barrier Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Blood Brain Barrier Technologies Revenue Market Share by Type (2019-2024)
Table 28. Global Blood Brain Barrier Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Blood Brain Barrier Technologies Revenue Market Share by Type (2025-2030)
Table 30. Global Blood Brain Barrier Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Blood Brain Barrier Technologies Revenue Market Share by Application (2019-2024)
Table 32. Global Blood Brain Barrier Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Blood Brain Barrier Technologies Revenue Market Share by Application (2025-2030)
Table 34. North America Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Blood Brain Barrier Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 49. Teva Pharmaceutical Industries Ltd. Company Detail
Table 50. Teva Pharmaceutical Industries Ltd. Business Overview
Table 51. Teva Pharmaceutical Industries Ltd. Blood Brain Barrier Technologies Product
Table 52. Teva Pharmaceutical Industries Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 53. Teva Pharmaceutical Industries Ltd. Recent Development
Table 54. F. Hoffmann-La Roche Ltd. Company Detail
Table 55. F. Hoffmann-La Roche Ltd. Business Overview
Table 56. F. Hoffmann-La Roche Ltd. Blood Brain Barrier Technologies Product
Table 57. F. Hoffmann-La Roche Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 58. F. Hoffmann-La Roche Ltd. Recent Development
Table 59. Eli Lilly and Company. Company Detail
Table 60. Eli Lilly and Company. Business Overview
Table 61. Eli Lilly and Company. Blood Brain Barrier Technologies Product
Table 62. Eli Lilly and Company. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 63. Eli Lilly and Company. Recent Development
Table 64. Bristol-Myers Squibb Company Company Detail
Table 65. Bristol-Myers Squibb Company Business Overview
Table 66. Bristol-Myers Squibb Company Blood Brain Barrier Technologies Product
Table 67. Bristol-Myers Squibb Company Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Recent Development
Table 69. Pfizer, Inc. Company Detail
Table 70. Pfizer, Inc. Business Overview
Table 71. Pfizer, Inc. Blood Brain Barrier Technologies Product
Table 72. Pfizer, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 73. Pfizer, Inc. Recent Development
Table 74. Johnson and Johnson Services, Inc. Company Detail
Table 75. Johnson and Johnson Services, Inc. Business Overview
Table 76. Johnson and Johnson Services, Inc. Blood Brain Barrier Technologies Product
Table 77. Johnson and Johnson Services, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 78. Johnson and Johnson Services, Inc. Recent Development
Table 79. Fabre-Kramer Pharmaceuticals, Inc. Company Detail
Table 80. Fabre-Kramer Pharmaceuticals, Inc. Business Overview
Table 81. Fabre-Kramer Pharmaceuticals, Inc. Blood Brain Barrier Technologies Product
Table 82. Fabre-Kramer Pharmaceuticals, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 83. Fabre-Kramer Pharmaceuticals, Inc. Recent Development
Table 84. Bioasis Technologies Inc. Company Detail
Table 85. Bioasis Technologies Inc. Business Overview
Table 86. Bioasis Technologies Inc. Blood Brain Barrier Technologies Product
Table 87. Bioasis Technologies Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 88. Bioasis Technologies Inc. Recent Development
Table 89. Abliva AB Company Detail
Table 90. Abliva AB Business Overview
Table 91. Abliva AB Blood Brain Barrier Technologies Product
Table 92. Abliva AB Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 93. Abliva AB Recent Development
Table 94. JCR Pharmaceuticals Co., Ltd. Company Detail
Table 95. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 96. JCR Pharmaceuticals Co., Ltd. Blood Brain Barrier Technologies Product
Table 97. JCR Pharmaceuticals Co., Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 98. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Brain Barrier Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Blood Brain Barrier Technologies Market Share by Type: 2023 VS 2030
Figure 3. Bispecific Antibody RMT Approach Features
Figure 4. Trojan Horse Approach Features
Figure 5. Increasing Permeability Features
Figure 6. Passive Diffusion Features
Figure 7. Others Features
Figure 8. Global Blood Brain Barrier Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Blood Brain Barrier Technologies Market Share by Application: 2023 VS 2030
Figure 10. Alzheimer’s Disease Case Studies
Figure 11. Epilepsy Case Studies
Figure 12. Parkinson’s Disease Case Studies
Figure 13. Multiple Sclerosis Case Studies
Figure 14. Hunter’s Syndrome Case Studies
Figure 15. Brain Cancer Case Studies
Figure 16. Others Case Studies
Figure 17. Blood Brain Barrier Technologies Report Years Considered
Figure 18. Global Blood Brain Barrier Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Blood Brain Barrier Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Blood Brain Barrier Technologies Market Share by Region: 2023 VS 2030
Figure 21. Global Blood Brain Barrier Technologies Market Share by Players in 2023
Figure 22. Global Top Blood Brain Barrier Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Brain Barrier Technologies as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Blood Brain Barrier Technologies Revenue in 2023
Figure 24. North America Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 26. United States Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 30. Germany Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Blood Brain Barrier Technologies Market Share by Region (2019-2030)
Figure 38. China Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 46. Mexico Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 50. Turkey Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 53. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 54. Eli Lilly and Company. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 56. Pfizer, Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 57. Johnson and Johnson Services, Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 58. Fabre-Kramer Pharmaceuticals, Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 59. Bioasis Technologies Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 60. Abliva AB Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 61. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Blood Brain Barrier Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Bispecific Antibody RMT Approach
Table 3. Key Players of Trojan Horse Approach
Table 4. Key Players of Increasing Permeability
Table 5. Key Players of Passive Diffusion
Table 6. Key Players of Others
Table 7. Global Blood Brain Barrier Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Blood Brain Barrier Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Blood Brain Barrier Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Blood Brain Barrier Technologies Market Share by Region (2019-2024)
Table 11. Global Blood Brain Barrier Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Blood Brain Barrier Technologies Market Share by Region (2025-2030)
Table 13. Blood Brain Barrier Technologies Market Trends
Table 14. Blood Brain Barrier Technologies Market Drivers
Table 15. Blood Brain Barrier Technologies Market Challenges
Table 16. Blood Brain Barrier Technologies Market Restraints
Table 17. Global Blood Brain Barrier Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Blood Brain Barrier Technologies Market Share by Players (2019-2024)
Table 19. Global Top Blood Brain Barrier Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Brain Barrier Technologies as of 2023)
Table 20. Ranking of Global Top Blood Brain Barrier Technologies Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Blood Brain Barrier Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Blood Brain Barrier Technologies Product Solution and Service
Table 24. Date of Enter into Blood Brain Barrier Technologies Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Brain Barrier Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Blood Brain Barrier Technologies Revenue Market Share by Type (2019-2024)
Table 28. Global Blood Brain Barrier Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Blood Brain Barrier Technologies Revenue Market Share by Type (2025-2030)
Table 30. Global Blood Brain Barrier Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Blood Brain Barrier Technologies Revenue Market Share by Application (2019-2024)
Table 32. Global Blood Brain Barrier Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Blood Brain Barrier Technologies Revenue Market Share by Application (2025-2030)
Table 34. North America Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Blood Brain Barrier Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Blood Brain Barrier Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Blood Brain Barrier Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Blood Brain Barrier Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 49. Teva Pharmaceutical Industries Ltd. Company Detail
Table 50. Teva Pharmaceutical Industries Ltd. Business Overview
Table 51. Teva Pharmaceutical Industries Ltd. Blood Brain Barrier Technologies Product
Table 52. Teva Pharmaceutical Industries Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 53. Teva Pharmaceutical Industries Ltd. Recent Development
Table 54. F. Hoffmann-La Roche Ltd. Company Detail
Table 55. F. Hoffmann-La Roche Ltd. Business Overview
Table 56. F. Hoffmann-La Roche Ltd. Blood Brain Barrier Technologies Product
Table 57. F. Hoffmann-La Roche Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 58. F. Hoffmann-La Roche Ltd. Recent Development
Table 59. Eli Lilly and Company. Company Detail
Table 60. Eli Lilly and Company. Business Overview
Table 61. Eli Lilly and Company. Blood Brain Barrier Technologies Product
Table 62. Eli Lilly and Company. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 63. Eli Lilly and Company. Recent Development
Table 64. Bristol-Myers Squibb Company Company Detail
Table 65. Bristol-Myers Squibb Company Business Overview
Table 66. Bristol-Myers Squibb Company Blood Brain Barrier Technologies Product
Table 67. Bristol-Myers Squibb Company Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 68. Bristol-Myers Squibb Company Recent Development
Table 69. Pfizer, Inc. Company Detail
Table 70. Pfizer, Inc. Business Overview
Table 71. Pfizer, Inc. Blood Brain Barrier Technologies Product
Table 72. Pfizer, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 73. Pfizer, Inc. Recent Development
Table 74. Johnson and Johnson Services, Inc. Company Detail
Table 75. Johnson and Johnson Services, Inc. Business Overview
Table 76. Johnson and Johnson Services, Inc. Blood Brain Barrier Technologies Product
Table 77. Johnson and Johnson Services, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 78. Johnson and Johnson Services, Inc. Recent Development
Table 79. Fabre-Kramer Pharmaceuticals, Inc. Company Detail
Table 80. Fabre-Kramer Pharmaceuticals, Inc. Business Overview
Table 81. Fabre-Kramer Pharmaceuticals, Inc. Blood Brain Barrier Technologies Product
Table 82. Fabre-Kramer Pharmaceuticals, Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 83. Fabre-Kramer Pharmaceuticals, Inc. Recent Development
Table 84. Bioasis Technologies Inc. Company Detail
Table 85. Bioasis Technologies Inc. Business Overview
Table 86. Bioasis Technologies Inc. Blood Brain Barrier Technologies Product
Table 87. Bioasis Technologies Inc. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 88. Bioasis Technologies Inc. Recent Development
Table 89. Abliva AB Company Detail
Table 90. Abliva AB Business Overview
Table 91. Abliva AB Blood Brain Barrier Technologies Product
Table 92. Abliva AB Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 93. Abliva AB Recent Development
Table 94. JCR Pharmaceuticals Co., Ltd. Company Detail
Table 95. JCR Pharmaceuticals Co., Ltd. Business Overview
Table 96. JCR Pharmaceuticals Co., Ltd. Blood Brain Barrier Technologies Product
Table 97. JCR Pharmaceuticals Co., Ltd. Revenue in Blood Brain Barrier Technologies Business (2019-2024) & (US$ Million)
Table 98. JCR Pharmaceuticals Co., Ltd. Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Brain Barrier Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Blood Brain Barrier Technologies Market Share by Type: 2023 VS 2030
Figure 3. Bispecific Antibody RMT Approach Features
Figure 4. Trojan Horse Approach Features
Figure 5. Increasing Permeability Features
Figure 6. Passive Diffusion Features
Figure 7. Others Features
Figure 8. Global Blood Brain Barrier Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Blood Brain Barrier Technologies Market Share by Application: 2023 VS 2030
Figure 10. Alzheimer’s Disease Case Studies
Figure 11. Epilepsy Case Studies
Figure 12. Parkinson’s Disease Case Studies
Figure 13. Multiple Sclerosis Case Studies
Figure 14. Hunter’s Syndrome Case Studies
Figure 15. Brain Cancer Case Studies
Figure 16. Others Case Studies
Figure 17. Blood Brain Barrier Technologies Report Years Considered
Figure 18. Global Blood Brain Barrier Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 19. Global Blood Brain Barrier Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 20. Global Blood Brain Barrier Technologies Market Share by Region: 2023 VS 2030
Figure 21. Global Blood Brain Barrier Technologies Market Share by Players in 2023
Figure 22. Global Top Blood Brain Barrier Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Brain Barrier Technologies as of 2023)
Figure 23. The Top 10 and 5 Players Market Share by Blood Brain Barrier Technologies Revenue in 2023
Figure 24. North America Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 26. United States Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Canada Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 30. Germany Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. France Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. U.K. Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Italy Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Russia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Nordic Countries Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Blood Brain Barrier Technologies Market Share by Region (2019-2030)
Figure 38. China Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Japan Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. India Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Australia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 46. Mexico Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Brazil Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Blood Brain Barrier Technologies Market Share by Country (2019-2030)
Figure 50. Turkey Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Blood Brain Barrier Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 53. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 54. Eli Lilly and Company. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 56. Pfizer, Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 57. Johnson and Johnson Services, Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 58. Fabre-Kramer Pharmaceuticals, Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 59. Bioasis Technologies Inc. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 60. Abliva AB Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 61. JCR Pharmaceuticals Co., Ltd. Revenue Growth Rate in Blood Brain Barrier Technologies Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232